In contrast, the other four trials [25], [27], [28], [30] did not report recommended fixed target doses of ACE inhibitor therapy, although in one trial clinicians were advised to target the doses of ACE inhibitors known to reduce morbidity and mortality in patients with congestive heart failure [27]. Here, ACE is linked to congestive heart failure.